CAS RN: 1776055-05-0
ML233
Product Availability
Choose a grade to view its available package options.
6 package records4 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251208 |
2mg / 5mg |
Out of stock |
| 5-7 business days | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20260516 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250131 |
10mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250729 |
250mg |
Out of stock |
| | Inquiry |
| Batchno.20250123 |
25mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20250525 |
50mg |
In stock |
Shanghai | | Inquiry |
-
Product code:
starshine_CAS1776055-05-0
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
1776055-05-0 / furan-3-yl-[4-[5-(furan-2-yl)-2-phenylpyrazolo[1,5-a]pyrimidin-7-yl]piperazin-1-yl]methanone
Standard CAS: 1776055-05-0
Multi CAS: No
Basic Information
CAS
1776055-05-0
Multi CAS
No
Molecular Formula
C25H21N5O3
Molecular Weight
439.500000
Exact Mass
439.164440
SMILES
C1CN(CCN1C2=CC(=NC3=CC(=NN32)C4=CC=CC=C4)C5=CC=CO5)C(=O)C6=COC=C6
InChI
InChI=1S/C25H21N5O3/c31-25(19-8-14-32-17-19)29-11-9-28(10-12-29)24-16-21(22-7-4-13-33-22)26-23-15-20(27-30(23)24)18-5-2-1-3-6-18/h1-8,13-17H,9-12H2
InChIKey
LRPGMVPQQLBMNE-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
33
Aromatic heavy atom count
25
Fraction Csp3
0.16
Rotatable bonds
4
H-bond acceptors
7
Molar refractivity
122.95
TPSA
80.02
LogP / Solubility
WLOGP
4.21
MLOGP
3.74
XLogP3
3.2
Consensus LogP
3.72
Log S (ESOL)
-5.51
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.2
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-6.49
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.41
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4